ArticleJournal of clinical and translational hepatology2026
A Multi-omics Investigation Identifies TACC3 as a Driver of Immunosuppression in Intrahepatic Cholangiocarcinoma via Activation of the STAT3-PD-L1 Axis.
Hao Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.